ada.enesco, Author at European Medical Journal - Page 17 of 27

Groundbreaking Discovery Offers New Hope for Diabetes Treatment

Novel findings pave the way for new diabetes treatments.

Probiotics and Prebiotics Alleviate Symptoms of Allergic Rhinitis

The trial found increased beneficial gut bacteria such as Lactobacillus and Bifidobacterium, alongside reduced pro-inflammatory species.

SGLT-2 Inhibitors Reduce Mortality in Diabetic Kidney Transplant Recipients

SGLT-2 inhibitors significantly lower mortality and adverse events in diabetic kidney transplant recipients, study reveals.

Hydroxychloroquine Helps Prevent Relapses in Lupus After Steroid Withdrawal

Hydroxychloroquine reduces relapse risk in lupus patients after steroid withdrawal, offering a safer path to long-term disease stability.

Chewing Gum Reduces Risk of Preterm Birth

Xylitol-containing chewing gum use during pregnancy significantly reduced the occurrence of preterm births and low-birthweight deliveries.

Half of Early-Onset Cancer Patients Miss Fertility Preservation Discussions

A recent study from the REACT initiative highlights a significant gap in fertility preservation discussions for early-onset cancer patients, with nearly half reporting that they were not informed about fertility options before beginning treatment.

Low IL-18 Levels Predict Long COVID in Patients with Autoimmune Diseases

A new study has identified inflammatory biomarkers linked to long COVID in patients with systemic autoimmune rheumatic diseases.

How Does Coffee Alter the Gut Microbiome?

A large-scale analysis has revealed a significant link between coffee consumption and the gut microbiome, driven primarily by the presence of Lawsonibacter asaccharolyticus.

Machine Learning Models Predict Success in Stopping Renal Replacement Therapy

Machine learning identifies key factors and predicts success in renal replacement therapy discontinuation for critically ill patients with acute kidney injury.

Rising Trends in Germline Genetic Testing for Prostate Cancer

Recent data shows a significant increase in germline genetic testing for prostate cancer, with a notable rise in urologist involvement.